Loading viewer...
earnings
Format: PDF earnings
Moderna presents its fourth quarter and full year 2022 financial results, covering revenue from COVID-19 vaccines, pipeline progress on RSV and personalized cancer vaccines, and 2023 guidance. The presentation includes business review, R&D updates, commercial strategy, and financial outlook from CEO Stéphane Bancel and leadership team.
conference
25 Pages
earnings
14 Pages
Scout24 SE
Western Midstream Partners WES Q1 2024 Earnings Review
earningsearnings
42 Pages
Western Midstream Partners
Action Construction Equipment Q2 FY2026 Earnings Call Transcript
earningsearnings
17 Pages
Action Construction Equipment Limited